Skip to main content

Table 2 Period means and ranges for pre- and 10 min post-allergen challenge mean TNSS and mean nasal PIF over the last three days of the allergen challenge series.

From: Effects of a dual CCR3 and H1-antagonist on symptoms and eosinophilic inflammation in allergic rhinitis

   

Pre challenge

10 min post challenge

Variable

Treatment

n

Mean

Range

Mean

Range

TNSS

AZD3778

35

1.25

0, 3

4.11

0.7, 7.7

 

Loratadine

35

1.64

0, 8

3.85

1, 8

 

Placebo

34

1.56

0, 5.5

5.57

1.7, 9

Nasal

PIF

AZD3778

35

179

76.7, 247

125

50, 200

 

Loratadine

35

165

50, 243

114

30, 210

 

Placebo

34

177

100, 257

108

57, 177